CORONA REMEDIES LIMITED
₹ 1008 - ₹ 1062
08-Dec-2025 - 10-Dec-2025
₹ 14868.00

/ 14 Shares

CORONA REMEDIES LIMITED

08-Dec-2025 - 10-Dec-2025

₹ 1008 - ₹ 1062

Price Band

₹ 14868.00

Minimum Investment

14

Bid Lot

6,116,015

Shares

  • Face Value - ₹ 10/- Per Share

  • Listing at BSE, NSE

  • 152,900 Application Required in Retail for 1 Time.

  • Registrar : Bigshare Services Pvt. Ltd

IPO Details

Category % Shares/Amount
QIB 50% 3,058,007 Shares RS.324.60 CR
HNI 1 5% 305,801 Shares RS.32.46 CR @ 1560 FORM 1X
HNI 2 10% 611,602 Shares RS.64.95 CR @ 3120 FORM 1X
Retail 35% 2,140,605 Shares RS.227.33 CR @ 152900 FORM 1X

Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
152900 FORM 1X 1560 FORM 1X 3120 FORM 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 14 ₹ 14,868
Retail (Upto 2 Lakh) 13 182 ₹ 193,284
S-HNI (2 Lakh to 10 Lakh) 14 196 ₹ 208,152
S-HNI (2 Lakh to 10 Lakh) 67 938 ₹ 996,156
B-HNI (Above 10 Lakh) 68 952 ₹ 1,011,024

IPO Timeline

  • Open Date

    08-Dec-2025

  • Close Date

    10-Dec-2025

  • Basis of Allotment Date

    11-Dec-2025

  • Initiation of Refunds

    12-Dec-2025

  • Credit Shares to Demat A/c

    12-Dec-2025

  • IPO Listing Date

    15-Dec-2025

Subscription as on
08-Dec-2025 15:05

Category Book Size Subscription No. of Times
QIB 1,223,203 ₹ 129.90 Cr. 1,540 ₹ 0.16 Cr. 0.00x
HNI (<10 LAKH) 305,801 ₹ 32.48 Cr. 330,554 ₹ 35.10 Cr. 1.08x
HNI2 (>10 LAKH) 611,602 ₹ 64.95 Cr. 195,692 ₹ 20.78 Cr. 0.32x
RETAIL 2,140,605 ₹ 227.33 Cr. 1,630,090 ₹ 173.12 Cr. 0.76x
Total 4,281,211 2,157,876 0.50x
Category Book Size Subscription No. of Times
QIB 1,223,203 ₹ 129.90 Cr. 1,540 ₹ 0.16 Cr. 0.00x
HNI (<10 LAKH) 305,801 ₹ 32.48 Cr. 330,554 ₹ 35.10 Cr. 1.08x
HNI2 (>10 LAKH) 611,602 ₹ 64.95 Cr. 195,692 ₹ 20.78 Cr. 0.32x
RETAIL 2,140,605 ₹ 227.33 Cr. 1,630,090 ₹ 173.12 Cr. 0.76x
Total 4,281,211 2,157,876 0.50x

*Excluding Anchor

Total No. of Application Approx : ~89380 (0.58 Appwise)

Appwise Subscription
Category Total App App wise
HNIBT 1513.81 1560 (For 1x) 0.97x
HNIAT 189.59 3120 (For 1x) 0.06x
RETAIL 88130.00 152900 (For 1x) 0.58x

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas.

As of June 30, 2025, the company's diverse portfolio includes 71 brands across therapeutic areas like women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory).

The company has a pan-India marketing and distribution network with 2,671 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas.

The company has two manufacturing facilities, located in the states of Gujarat with an aggregate installed capacity for formulations of 1,285.44 million units per annum.

Read More

Strengths

  • Second fastest growing company in the top 30 Indian pharmaceutical companies by domestic sales from MAT June 2022 to MAT June 2025, well-positioned to seize opportunities in the Indian market.
  • Demonstrated capabilities of building a diversified portfolio, including “engine” brands, in our targeted therapy areas.
  • Pan-India sales network and marketing strategy focused on the “middle of the pyramid” target market.
  • Quality and current Good Manufacturing Practices-focused manufacturing facilities, with strong research and development capabilities driving a portfolio of differentiated pharmaceutical products.
  • Qualified, experienced and entrepreneurial management team supported by marquee investors.

Company Promoters

Company Financials

Corona Remedies Ltd.'s revenue increased by 18% and profit after tax (PAT) rose by 65% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended 30 Jun 2025 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 1,012.38 929.86 830.58 595.02
Total Income 348.56 1,202.35 1,020.93 891.10
Profit After Tax 46.20 149.43 90.50 84.93
EBITDA 71.80 245.91 161.19 135.03
NET Worth 607.02 606.34 480.41 408.52
Reserves and Surplus 545.86 545.18 419.25 347.36
Total Borrowing 106.65 62.70 134.14 2.33
Amount in ? Crore

Objects of the Issue

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to Us.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with Us, in just a few clicks your application is processed. You can bid for any IPO through Us, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Apply Now
Message!!

Your file has been successfully uploaded.